e-learning
resources
Munich 2006
Tuesday 05.09.2006
Clinical physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchial resistance of community acquired pneumonia patients
F. F. Tetenev, T. S. Ageeva, V. Y. Danilenko, A. V. Dubakov (Tomsk, Russian Federation)
Source:
Annual Congress 2006 - Clinical physiology
Session:
Clinical physiology
Session type:
Thematic Poster Session
Number:
3809
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. F. Tetenev, T. S. Ageeva, V. Y. Danilenko, A. V. Dubakov (Tomsk, Russian Federation). Bronchial resistance of community acquired pneumonia patients. Eur Respir J 2006; 28: Suppl. 50, 3809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Mortality in patients with COPD due to community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Frequency of antibiotic resistance and outcomes in severe community acquired pneumonia due to
Streptococcus pneumoniae
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Cardiac diseases in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Diagnosis and management of community acquired pneumonia in adults
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020
Management of community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Management of community acquired pneumonia
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Management of severe community acquired pneumonia
Source: Virtual Congress 2020 – German programme 2020
Year: 2020
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Common pathogens in bronchial secretions of the ICU patients with nosocomial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 405s
Year: 2001
Severe mixed community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Defining stability in pneumonia and the non-responding pneumonia
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
Hyperglycaemia in children with community acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 318s
Year: 2003
Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Lymphotropic therapy of community acquired pneumonias associated with pulmonary destruction
Source: Eur Respir J 2006; 28: Suppl. 50, 166s
Year: 2006
Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Bacterial infection in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 159s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept